Characterization of bone repair in rat femur after treatment with calcium phosphate cement and autogenous bone graft
© Puricelli et al; licensee BioMed Central Ltd. 2010
Received: 7 December 2009
Accepted: 28 June 2010
Published: 28 June 2010
In this study, the biocompatibility, stability and osteotransductivity of a new cement based on alpha-tricalcium phosphate (alpha-TCP) were investigated in a bone repair model using a rat model.
The potential of alpha-TCP on bone repair was compared to autogenous bone grafting, and unfilled cavities were used as negative control. Surgical cavities were prepared and designated as test (T), implanted with alpha-TCP blocks; negative control (C - ), unfilled; and positive control (C + ), implanted with autogenous bone graft. Results were analyzed on postoperative days three, seven, 14, 21 and 60.
The histological analyses showed the following results. Postoperative day three: presence of inflammatory infiltrate, erythrocytes and proliferating fibroblasts in T, C - and C + samples. Day seven: extensive bone neoformation in groups T and C + , and beginning of alpha-TCP resorption by phagocytic cells. Days 14 and 21: osteoblastic activity in the three types of cavities. Day 60: In all samples, neoformed bone similar to surrounding bone. Moderate interruption on the ostectomized cortical bone.
Bone neoformation is seen seven days after implantation of alpha-TCP and autogenous bone. Comparison of C - with T and C + samples showed that repair is faster in implanted cavities; on day 60, control groups presented almost complete bone repair. Alpha-TCP cement presents biocompatibility and osteotransductivity, besides stability, but 60 days after surgery the cavities were not closed.
Bone exists in two main structural types: primary bone and lamellar or secondary bone . Bone repair occurs in a process that may take months or years . The morphological and functional recovery of hard tissues lost during the treatment of pathological processes and traumatic lesions has been extensively studied, and different approaches have been suggested.
Autogenous bone graft is considered to be the gold standard for replacement of lost tissue [3, 4]. Garg, in 1999 , defined the three processes associated to the fate of bone grafts: osteogenesis, osteoinduction and osteoconduction. Osteogenesis is formation of bone, whereas osteoinduction is the process by which osteogenesis is induced and osteoconduction is a physiologic process whereby a conductor provides a physical matrix for deposition of new bone tissue. Advancements in surgical techniques to collect human bone for autogenous grafting are not able to keep pace with the evolution in the production of alloplastic material, such as calcium phosphate cements , which have been successfully used for bone repair in the last decade.
The ideal material must be biocompatible, bioactive and resorbable . Other desirable characteristics include unlimited availability, stability and ability of filling and conformation . Scaffold design is of primordial importance for the success of bone tissue-engineering grafts, and a wide variety of biomaterials, including polymers, ceramics and composites) are under investigation for bone repair (reviewed by Fröhlich et al. ). The association of biomaterials with stem/progenitor cells  or their use as vehicles for cytokines, growth factors or genes for bone formation  represent important additions to the field of regenerative medicine. Presently, however, no single biomaterial available for bone repair and regeneration presents all the properties required for an ideal bone graft (reviewed by ), and new combinations of materials are under intensive research.
Brown and Chow (1986)  were the first to propose the use of calcium phosphate cement in bone repair. Its biocompatibility, bioactivity and osteoconductivity have been shown in many studies [14–17], and its biological behavior has been investigated in vivo[6, 18]. In general, these cements are absorbed by the intense activity of the phagocytic system, leading to the simultaneous formation of new bone tissue in the interface bone/implant. This process is called osteotransductivity . Knabe et al.  suggested that it is a slow process, which continues in average for two years after implantation. Toquet et al.  analyzed the osteogenic potential of human bone marrow cells during in vitro culture on calcium phosphate ceramics, showing that the cells populated the pores of the material.
Santos, in 2002 , developed a new cement based on alpha-tricalcium phosphate [Ca 3(PO 4) 2] (alpha-TCP) by adding a fluid reducer, ammonium polyacrylate, to this material. This new type of calcium phosphate showed greater resistance to mechanical stress while maintaining the characteristics of osteotransductivity and biocompatibility. Considering the therapeutic potential of calcium phosphate cements, the present work aimed to contribute to this area of research by the histological analyses of the effect of a new type of biomaterial, alpha-tricalcium phosphate cement, as compared to autogenous bone grafting, during bone repair in surgically created cavities. Characteristics of alpha-TCP, such as biocompatibility, stability and osteotransductivity were also investigated.
The study was conducted in a rat model, in which surgical cavities were created according to the protocol established by Puricelli [23, 24]. The bone cavity has only one ruptured cortical margin, allowing a type of fixation of the bone fragments as an essential condition for the production of a bone callus. Although more frequently critical-sized bone defects of 5 mm are created to assess healing progress in rats, smaller defects are also used. Cao and Kuboyama , for instance, compared the therapeutic potential of scaffolds composed of polyglycolic acid and beta-tricalcium phosphate (PGA/β-TCP) or hydroxylapatite, in a rat model in which 3 mm × 2 mm femur defects were made. Studies conducted by our group [19, 20, 26, 27] have also shown that 2 mm × 4 mm cavities, surgically induced on the cortical surface of the femur, represent an adequate model to investigate the role of different materials and processes on bone healing.
This controlled experimental study was conducted in the Laboratory of Experimental Surgery of the Oral and Maxillofacial Surgery and Traumatology Discipline, School of Dentistry of Universidade Federal do Rio Grande do Sul (UFRGS). The biomaterial used was produced in the Department of Materials of the School of Mechanical Engineering UFRGS. Thirty precured, cylindrical blocks of alpha-tricalcium phosphate (alpha-TCP) with 2 mm diameter and 4 mm length were produced. The material was sterilized in hydrogen peroxide, following methods established at Hospital de Clínicas de Porto Alegre (HCPA, 2002) and Corsetti et al. .
Thirty 5-month old male Wistar rats were used, an age at which sexual/social maturity is reached. The animals were housed and maintained in accordance with the guidelines for the care of laboratory animals, Normative Resolution 04/97, prepared by the Ethics and Health Research Committee/GPPG/HCPA. The project was approved by the Research Ethics Committee of the School of Dentistry of Universidade Federal do Rio Grande do Sul.
The animals were anesthetized and the right hind leg was shaved and the skin disinfected. A 3 cm incision was made on the skin, the tissues were separated by layers and the periosteum was incised with a scalpel. Surgical cavities were prepared on the cortical surface of the femur with help of a perforated titanium surgical splint. Three cavities were produced with a slow-rotation trephine bur, under constant irrigation with physiological saline solution and aspiration. The cavities, measuring 2 mm wide and 4 mm deep, were designated as test (T), negative control (C - ) and positive control (C + ), from proximal to distal.
The sample was randomly selected, with two control and one experimental groups. The rats were divided into five groups (n = 6 each), analyzed in different periods after the experimental procedure: three, seven, 14, 21 and 60 postoperative days. The animals were euthanized, and the right hind leg was stored in 10% neutral buffered formalin. The material included in paraffin was prepared with a microtome, following the femoral long axis.
Sections were stained with hematoxylin and eosin, and mounted with Canada balsam. Slides were analyzed with an optical microscope (Model Lambda LQT 2, ATTO Instruments Co., Hong Kong, China), with 40, 100, 250 and 400 magnification. Bone repair was qualitatively evaluated and compared among different groups.
This study is in accordance with the guidelines for animal research established by the State Code for Animal Protection and Normative Rule 04/97 from the Research and Ethics in Health Committee/GPPG/HCPA.
All samples presented a marked regular interruption of the ostectomized cortical bone, without dislocation of the alpha-TCP block (Figure 3). On postoperative day 3, an intense inflammatory infiltrate, erythrocytes and proliferating fibroblasts were observed, but no bone neoformation (Figure 3). Evident bone neoformation, beginning on the endosteum around the alpha-TCP block, along with granulation tissue characterized by angiogenesis and fiberplasia, were observed on day 7 (Figure 4). Irregularities could be seen on the border of the cement block, with macrophages and giant multinucleated cells (Figure 5).
On postoperative day 14, the neoformation of trabecular bone was evidenced by the reversal (basophil) line, as well as concentric cell areas with bone formation within the block (Figure 6). On day 21, areas of bone tissue in different maturation degrees were observed, with regression of the inflammatory activity and less fibrous tissue in the region. The regularity of the implant-bone surface interface was noteworthy (Figure 7). The marginal bone neoformation was well organized, with bone isthmus invasion and establishment in occasional irregularities of the implanted inorganic structure. On day 60, mature bone tissue replaced the immature tissue. The surface of the alpha-TCP block was invaded by cells, and an outline of neoformed bone surrounded the bone/implant interface (Figure 8).
C - cavity
A markedly regular interruption of the ostectomized cortical bone was observed in all samples. Three days after the surgery, no bone neoformation was observed. An inflammatory infiltrate and intense fibroblastic proliferation were seen in the medullary space. The fiberplasia process, started in the periosteum, showed invagination towards the cavity (Figure 3). The medullary tissue surrounding the cavity had altered continuity and was rich in megakariocytes. Seven days after surgery, intense fiberplasia was seen, and no bone neoformation (Figure 4). Erythrocytes, moderate angiogenesis and an inflammatory infiltrate were observed in the medullary compartment. On day 14, the samples showed bone neoformation, of a predominantly endosteal nature, blocking the interruption between the cortical areas, and reduced levels of inflammatory infiltrate and fibrous tissue (Figure 6). On day 21, the cortical organization could be seen by the presence of trabecular projections, with maturation of lamellar bone whose thickness was compatible with the original bone structure of the region (Figure 7). The ordered presence of adipocytes in the bone marrow showed that the hematopoietic tissue was mature. On Day 60, there was a small indent in the cortex suggestive of wound healing (Figure 8). The dimension and cellular aspect of the medullary channel returned to normal conditions.
C + cavity
A markedly regular interruption in the ostectomized cortical bone was observed in all samples. On day 7, accelerated bone neoformation was observed (Figure 4). On day 14, primary bone tissue and osteoblastic cells were seen (Figure 6). The reversal line (basophil line) was also observed between the lamellar and primary bone tissues. The hematopoietic bone marrow showed a tendency towards a normal aspect. On postoperative day 21, the upper surface of the cavity presented bone tissue in different degrees of maturation and osteoblasts which merged its structure with that of the graft surface (Figure 7). On day 60, progressive bone neoformation induced by osteoblasts was seen, as well as bone repair confirmed by the closure of the cortical bone (Figure 8).
The experimental protocol used in this work, established by Puricelli and colleagues [23, 24, 26, 27], has proven very adequate for this type of study. The ostectomized cortical structure showed marked regularity, in all groups and experimental periods investigated. Three and 7 days after surgery, all samples showed the presence of granulation tissue in the cavities, previously described by Junqueira and Carneiro  and Burkitt et al. .
The biological properties of autogenous bone grafting, considered to be the gold standard [3–5], could be observed seven days after surgery, with an accelerated process of bone neoformation, as compared to the negative control group. The present study also showed that alpha-TCP blocks filled the surgical cavities without the development of inflammatory reactions of significant extension or duration, as already shown in other studies [16, 17].
In the present work, we used histological parameters to monitor the process of bone healing. The progress of fracture healing is often difficult to assess, and clinicians have to rely on subjective parameters such as pain or tenderness to palpation to monitor this process. A consistent definition of bone healing is lacking (reviewed by ), and many biological markers which are easy to assess on radiographic examination have shown poor correlation with mechanical strength . More recently developed methods, such as micro-computed tomography (micro-CT  or structural rigidity analysis , have shown potential in monitoring the progression of fracture healing over time. Histological analysis, however, is still considered a valuable tool to asses fracture healing, and has shown good correlation with quantitative methods. In a study aiming to evaluate the role of endothelial progenitor cells on bone regeneration in a rat model, healing was evaluated with radiographic, histological, and micro-CT scans . Histological results, showing that cell-treated animals had significantly higher levels of new bone and vessel formation than controls, correlated with radiographic and micro-CT assessments showing significantly improved parameters of bone volume, density, trabecular number, thickness and spacing, as well as bone surface and bone surface to bone volume ratio for the treated group compared to control.
According to Schenk et al. , the ideal biomaterial should show resorption during the remodeling phase, being replaced by bone tissue. These histological results support previous studies by Parker (1995)  showing that, simultaneous to bone neoformation in the bone/implant interface, the cement is phagocytosed by macrophages and multinucleated giant cells, adding osteotransductivity to its properties. Cavities filled with the alpha-TCP cement showed, as early as seven days after surgery, accelerated bone neoformation, surrounding the cement blocks. On day 14, concentric cellular areas with bone formation were observed in the interior of the blocks. Similar results were reported by Toquet et al. .
In a meta-analysis of histomorphometry and graft healing time of different types of biomaterials used as sinus floor augmentation material in humans, Klijn et al.  concluded that autologous bone is still the gold standard. Allogenic, xenogenic or alloplastic graft materials resulted in a significantly lower amount of bone volume as compared to autologous bone grafting. However, a wide variety of scaffolds have shown therapeutic results on the repair of bone defects. Gunatillake and Adhikari  reviewed the role of biodegradable synthetic polymers in bone healing, showing their potential in many types of clinical applications. The therapeutic potential of PGA/β-TCP was studied in a rat model . The scaffold presented strong ability for osteogenesis, mineralization and biodegradation for bone replacement.
The alpha-TCP cement formulated by Santos (2002)  has the stability property proposed by Shindo et al.  as important for biomaterials. Our results showed that, in all groups, bone neoformation involved initially the formation of immature primary bone that was progressively remodeled for production of mature lamellar bone. This process is well known in humans, as described by Burkitt, Young and Heath (1994)  and Junqueira and Carneiro (2004) . The design used in the present study did not allow for the investigation of a role for the periosteum in this process. The importance of the periosteum for nutrition of the augmentation area during bone healing has been already described . Due to this activity, which seems to be induced by Bone Morphogenetic Proteins (BMPs) , surgeons try to preserve the periosteum while treating bone defects.
Sixty days after surgery, a slight interruption of the ostectomized cortical bone could be seen in C - and C + cavities, whereas in the T cavities there was no occlusion on the cavity roof. As already pointed by Schilling et al. , the bone repair process may take months to years to be completed. Resorption of calcium phosphate cements is slow, and the biomaterial may last for up to two years after implantation .
The histologic results of the present study show that, in rats, the alpha-tricalcium phosphate [Ca 3(PO 4) 2] developed by Santos (2002)  presents the properties of biocompatibility, osteotransductivity and stability. The repair process was initially faster in filled (T and C + ) cavities than in non-implanted (C - ) cavities. The results suggest that the analysis of resorption of this cement should be performed in periods longer than 60 days after surgery.
We would like to thank Prof. Lucienne Miranda Ulbrich (Centro Universitário Positivo - UnicenP) and Isabel Regina Pucci (Manager, Instituto Puricelli & Associados).
- Burkitt HG, Young B, Heath JW: Wheater Histologia Funcional. 1994, Rio de Janeiro: Guanabara Koogan, 3
- Schilling T, Müller M, Minne HW, Ziegler R: Influence of inflammation-mediated osteopenia on the regional acceleratory phenomenon and the systemic acceleratory phenomenon during healing of a bone defect in the rat. Calcif Tissue Int. 1998, 63: 160-166. 10.1007/s002239900508.View ArticlePubMed
- Puricelli E, Chem RC: Reconstrução de mandíbula com fíbula. Rev Gaúcha Odontol. 1985, 33: 124-127.
- Puricelli E, Baraldi CE, Paris MF: Reconstruções ósseas alveolares. 2005, 23°CIOSP - Congresso Internacional de São Paulo, São Paulo, RS, Brazil, 20-virtual book, chapter XX
- Garg AK: Grafting materials in repair and restoration. Tissue Engineering: Applications in Maxillofacial Surgery and Periodontics. Edited by: Linch SE, Genco RJ, Marx RE. 1999, Chicago: Quintessence
- Kurashina K, Kurita H, Kotani A, Kobayashi S, Kyoshima K, Hirano M: Experimental cranioplasty and skeletal augmentation using an alpha-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement: a preliminary short-term experiment in rabbits. Biomaterials. 1998, 19: 701-706. 10.1016/S0142-9612(97)00178-6.View ArticlePubMed
- Schenk RK, Buser D, Hardwick WR, Dahlin C: Healing pattern of bone regeneration in membrane-protected defects: a histologic study in the canine mandible. Int J Oral Maxillofac Implants. 1994, 9: 13-29.PubMed
- Shindo ML, Costantino PD, Friedman CD, Chow LC: Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg. 1993, 119: 185-190.View ArticlePubMed
- Fröhlich M, Grayson WL, Wan LQ, Marolt D, Drobnic M, Vunjak-Novakovic G: Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther. 2008, 3: 254-264. 10.2174/157488808786733962.PubMed CentralView ArticlePubMed
- Braccini A, Wendt D, Farhadi J, Schaeren S, Heberer M, Martin I: The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J Tissue Eng Regen Med. 2007, 1: 60-65. 10.1002/term.11.View ArticlePubMed
- Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO: Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res. 2003, 18: 47-57. 10.1359/jbmr.2003.18.1.47.View ArticlePubMed
- Porter JR, Ruckh TT, Popat KC: Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog. 2009, 25: 1539-1560.PubMed
- Brown WE, Chow LC: A new calcium phosphate, water-setting cement. Cements Research Progress. Edited by: Brown PW. 1986, American Ceramic Society, Westerville, OH
- Driessen FCM, Boltong MG, Zapatero MI, Verbeeck RMH, Bonfield W, Bérmúdez O, Fernández E, Ginebra MP, Planell JA: In vivo behaviour of three calcium phosphate cements and a magnesium phosphate cement. J Mater Sci Mater Med. 1995, 6: 272-278. 10.1007/BF00120270.View Article
- Daculsi G, Passuti N, Martin S, Deudon C, Legeros RZ, Raher S: Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res. 1990, 24: 379-396. 10.1002/jbm.820240309.View ArticlePubMed
- Ishikawa K, Miyamoto Y, Takechi M, Toh T, Kon M, Nagayama M, Asaoka K: Non-decay type fast-setting calcium phosphate cement: setting behaviour in calf serum and its tissue response. Biomaterials. 1996, 17: 1429-1435. 10.1016/0142-9612(96)87286-3.View ArticlePubMed
- TenHuisen KS, Brown PW: Variations in solution chemistry during calcium-deficient and stoichiometric hydroxyapatite formation from CaHPO4.2H2O and Ca4(PO4)2O. J Biomed Mater Res. 1997, 36: 233-241. 10.1002/(SICI)1097-4636(199708)36:2<233::AID-JBM12>3.0.CO;2-H.View ArticlePubMed
- Moraes PC, Padilha Filho JG, Canola JC, Santos LA, Marcoris DG, Alessi AC, Castro MB, Dória Neto FA: Biocompatibilidade do cimento de fosfato de cálcio implantado no rádio de coelhos. Acta Cir Bras [serial online]. 2004, 19-
- Parker RB: Injertos ósseos en cirugia de pequeños animales. Waltham Focus. 1995, 5: 90-99.
- Knabe C, Driessens FC, Planell JA, Gildenhaar R, Berger G, Reif D, Fitzner R, Radlanski RJ, Gross U: Evaluation of calcium phosphates and experimental calcium phosphate bone cements using osteogenic cultures. J Biomed Mater Res. 2000, 52: 498-508. 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P.View ArticlePubMed
- Toquet J, Rohanizadeh R, Guicheux J, Couillaud S, Passuti N, Daculsi G, Heymann D: Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic. J Biomed Mater Res. 1999, 44: 98-108. 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P.View ArticlePubMed
- Santos LA: Cimento de fosfato de cálcio reforçado por fibras. 1986, Universidade Estadual de Campinas, SP, Brazil, Thesis (Ph.D.)
- Ramires FB: Avaliação histológica da regeneração óssea guiada em ratos após enxerto ósseo autógeno e implante de membrana reabsorvível. 2001, Dissertation (M.Sc.), Dentistry School, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Ulbrich LM: Avaliação do efeito de um campo magnético permanente na cicatrização óssea em fêmures de ratos. 2003, Dissertation (M.Sc.), Dentistry School, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Cao H, Kuboyama N: A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering. Bone. 2010, 46: 386-395. 10.1016/j.bone.2009.09.031.View ArticlePubMed
- Puricelli E, Ulbrich LM, Ponzoni D, Filho JJ: Histological analysis of the effects of a static magnetic field on bone healing process in rat femurs. Head Face Med. 2006, 2: 43-10.1186/1746-160X-2-43.PubMed CentralView ArticlePubMed
- Puricelli E, Dutra NB, Ponzoni D: Histological evaluation of the influence of magnetic field application in autogenous bone grafts in rats. Head Face Med. 2009, 5: 1-10.1186/1746-160X-5-1.PubMed CentralView ArticlePubMed
- Corsetti A, Leite MGT, Ponzoni D, Puricelli E: Avaliação da presença de microrganismos aeróbios em blocos de cimento de fosfato de cálcio submetidos a três técnicas de esterilização. Rev Fac Odont Passo Fundo/RS. 2008, 13: 27-32.
- Junqueira LC, Carneiro J: Tecido Ósseo. Histologia Básica. Edited by: Junqueira LC, Carneiro J. 2004, Rio de Janeiro: Guanabara Koogan, 10
- Yuan H, Li Y, de Bruijn JD, de Groot K, Zhang X: Tissue responses of calcium phosphate cement: a study in dogs. Biomaterials. 2000, 21: 1283-1290. 10.1016/S0142-9612(00)00016-8.View ArticlePubMed
- Nazarian A, Pezzella L, Tseng A, Baldassarri S, Zurakowski D, Evans CH, Snyder BD: Application of structural rigidity analysis to assess fidelity of healed fractures in rat femurs with critical defects. Calcif Tissue Int. 2010, 86: 397-403. 10.1007/s00223-010-9353-4.PubMed CentralView ArticlePubMed
- Morshed S, Corrales L, Genant H, Miclau T: Outcome assessment in clinical trials of fracture-healing. J Bone Joint Surg Am. 2008, 90 (Suppl 1): 62-67. 10.2106/JBJS.G.01556.View ArticlePubMed
- Nyman JS, Munoz S, Jadhav S, Mansour A, Yoshii T, Mundy GR, Gutierrez GE: Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography. J Biomech. 2009, 42: 891-897. 10.1016/j.jbiomech.2009.01.016.View ArticlePubMed
- Atesok K, Li R, Stewart DJ, Schemitsch EH: Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res. 2010,
- Klijn RJ, Meijer GJ, Bronkhorst EM, Jansen JA: A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans. Tissue Eng Part B Rev.
- Gunatillake PA, Adhikari R: Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 2003, 5: 1-16.PubMed
- Spector M: Biomaterials-based tissue engineering and regenerative medicine solutions to musculoskeletal problems. Swiss Med Wkly. 2006, 136: 293-301.PubMed
- Yu YY, Lieu S, Lu C, Colnot C: Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.